AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
European Union -- A potential influenza pandemic remains currently of high public interest and the European Medicines Agency (EMEA) has provided a safety update on oseltamivir (Tamiflu[R]) see page 274).
Oseltamivir is an antiviral approved in the European Union for the treatment of influenza in children between 1 and 13 years of age and for the prevention and treatment of influenza in adolescents over 13 years and adults.
Two cases of alleged 'suicide' associated with treatment of influenza (involving a 17-year-old boy in February 2004 and a 14-year-old boy in February 2005) were reported to the EMEA. In both cases the adolescents exhibited abnormal/ …